Change Font Size

back

July 30, 2025

Licensing Agreement with Viridian Therapeutics for "Veligrotug" and "VRDN-003" in Treatment of Thyroid Eye Disease



Please see the attached file. 【PDF/161.6 KB】

Back to top of page